Ectin Research AB
ECTIN B | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0015987706 (+1 more)
- LEI:
- 549300IDDKUG9RWXFN04
- Country:
- Sweden
- Address:
- c/o Walthon Advokater, 102 43 Stockholm
- Website:
- https://www.ectinresearch.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Ectin Research AB is a clinical-stage pharmaceutical company focused on the research and development of novel treatments for cancer. The company's primary drug candidate, MFA-370, is a therapy being developed to eliminate cancerous tumors. The initial focus for clinical trials of MFA-370 is the treatment of metastatic bladder cancer. Ectin Research's objective is to commercialize its projects and knowledge derived from its research in medicine and biotechnology to diagnose and treat various forms of cancer.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Ectin Research AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Ectin Research AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Ectin Research AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
